Assessment of acceptance in use and self-assessment of a nasal spray (094840-01) under normal conditions of use

Allergisa Pesquisa Dermato-Cosmetica Ltda0 个研究点开始时间: 2023年2月5日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Healthy pediatric subjects; Intact skin on test site; Agreement of the child's legal guardian to adhere to the procedures and requirements of the study and to report to the institute on the day(s) and at the time(s) scheduled for the assessments; Ability by the guardian of consenting to the participation of the child in the study; Children aged from 6 months to 2 years and 11 months; Study subjects of any gender. Subjects presenting phototype (Fitzpatrick) I to IV;Users of products of the same category.

•Skin pathology on the area of product application; Diabetes; Immunological insufficiency.Current use of the following topical or systemic medications: corticosteroids, immunosuppressant and anti-histaminic drugs.Skin diseases: vitiligo, psoriasis, atopic dermatitis; History of reaction to the category of product tested; Other diseases or medications that might directly interfere with the study or put subject's health under risk.

发起方

Allergisa Pesquisa Dermato-Cosmetica Ltda